Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents. © 2008 Pulsus Group Inc. All rights reserved.
CITATION STYLE
Vahid, B., & Marik, P. E. (2008). Infiltrative lung diseases: Complications of novel antineoplastic agents in patients with hematological malignancies. Canadian Respiratory Journal. Hindawi Limited. https://doi.org/10.1155/2008/305234
Mendeley helps you to discover research relevant for your work.